Volume : 13, Issue : 07, July – 2026
Title:
DESIGN, PREPARE AND CHARACTERIZATION OF DONEPEZIL LIPOSOMAL DRUG DELIVERY SYSTEM
Authors :
A. Gopireddy*, Peechara Srividya, Rouhtu Divya
Abstract :
The drug release from Liposomes depends on many factors including the composition of Liposomes, the type of drug encapsulated and nature of the cell. Once it is released a drug that normally crosses the membrane of a cell will enter the cell, other drugs will not enter. Donepezil is a drug with narrow therapeutic index and short biological half-life. This study aimed at developing and optimizing liposomal formulation of Donepezil in order to improve its bioavailability. In evaluation study the effect of the varying composition of lipids on the properties such as encapsulation efficiency, particle size and drug release were studied. Phase transition study was carried out to confirm the complete interaction of Donepezil with bilayer structure of liposome. Moreover, the release of the drug was also modified and extended over a period of 8 hr in all formulations. F2 emerged as the most satisfactory formulation in so far as its properties were concerned. Further, release of the drug from the most satisfactory formulation (F2) was evaluated through dialysis membrane to get the idea of drug release.
Keywords: Liposomes, Donepezil , bioavailability, thin film hydration technique, in vitro drug release studies.
Cite This Article:
Please cite this article in press A.Gopireddy et al., Design, Prepare And Characterization Of Donepezil Liposomal Drug Delivery System, Indo Am. J. P. Sci, 2026; 13(07).
REFERENCES:
1. Benita S. Microencapsulation Method and Industrial Application, Drug and The Pharmaceutical sciences. Vol.73 2002. p. 213.
2. Fuji G. Vesicles, Realization of the Drug Delivery Concept. Vol.62 1996. New York p. 491-495.
3. Bangham AD, Standish MM. Diffusion of univalent ions across the lamella of swollen Phospholipids. J. Mol. Biol. 1965; 13: 238-252.
4. Vyas SP, Khar RK. Targeted and controlled Drug Delivery, Novel Carrier system, CBS Publishers and distributors. 2002. p. 249.
5. Gregoriadis G. Liposome technology, Liposome preparation and related techniques, 3rd edition, vol. l 2007. p. 21.
6. Singh S, Gulati M. Advances in liposomal therapeutics, Targeting of drugs to lipid bilayer in liposomes: an approach for the success of liposomes as delivery systems. CBS Publishers and distributors. New Delhi. 2001. p. 4-34.
7. Scherphof G, Morselt H, Regts J. The involvement of the lipid phase transition in the plasma-induced dissolution of multilamellar phosphatidylcholine vesicles. Biochem. Biophys. Acta.1979; 556:196–207.
8. Jain NK. Controlled and novel drug Delivery, CBS Publishers and distributors.2002. p. 305,326,330.
9. Bangham AD. Techniques in life Science, lipid membrane biochemistry. Elsevier scientific publications. Ireland. 1982 p.1-25.
10. Drummond DC, Meyer O, Hong K. Pharmacokinetic study of liposome encapsulated drug. Pharmacological reviews 1999; 51(4): 691-743.11.
11. Lasic DD. Stealth liposomes, Microencapsulation Method and Industrial Applications. Vol. 73 1996 p. 297-311.